BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 11134142)

  • 1. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
    Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
    Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
    Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
    Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
    J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined characterization of a pituitary adenoma and a subcutaneous lipoma in a MEN1 patient with a whole gene deletion.
    Rusconi D; Valtorta E; Rodeschini O; Giardino D; Lorenzo I; Predieri B; Losa M; Larizza L; Finelli P
    Cancer Genet; 2011 Jun; 204(6):309-15. PubMed ID: 21763627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
    Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
    Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
    Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.
    Prezant TR; Levine J; Melmed S
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1388-91. PubMed ID: 9543172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
    Ozturk M; Chiu CY; Akdeniz N; Jenq SF; Chang SC; Hsa CY; Jap TS
    J Endocrinol Invest; 2006 Jun; 29(6):523-7. PubMed ID: 16840830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.
    Stock JL; Warth MR; Teh BT; Coderre JA; Overdorf JH; Baumann G; Hintz RL; Hartman ML; Seizinger BR; Larsson C; Aronin N
    J Clin Endocrinol Metab; 1997 Feb; 82(2):486-92. PubMed ID: 9024241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma.
    Farrell WE; Azevedo MF; Batista DL; Smith A; Bourdeau I; Horvath A; Boguszewski M; Quezado M; Stratakis CA
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1905-14. PubMed ID: 21917868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
    Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
    Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
    Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
    Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
    Evans CO; Brown MR; Parks JS; Oyesiku NM
    J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1).
    Karges W; Schaaf L; Dralle H; Boehm BO
    Exp Clin Endocrinol Diabetes; 2000; 108(5):334-40. PubMed ID: 10989951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
    Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
    J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.